TGI
JNCE

TRV GP III’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,148,780
Closed -$2.69M 6
2022
Q3
$2.69M Hold
1,148,780
1.17% 6
2022
Q2
$3.48M Hold
1,148,780
1.42% 7
2022
Q1
$7.8M Hold
1,148,780
2.12% 7
2021
Q4
$9.59M Sell
1,148,780
-1,900,000
-62% -$15.9M 2.4% 7
2021
Q3
$22.7M Hold
3,048,780
4.3% 6
2021
Q2
$20.7M Hold
3,048,780
3.62% 7
2021
Q1
$31.3M Hold
3,048,780
3.96% 6
2020
Q4
$21.3M Hold
3,048,780
1.83% 7
2020
Q3
$24.9M Hold
3,048,780
2.09% 7
2020
Q2
$21M Hold
3,048,780
3.07% 5
2020
Q1
$14.5M Hold
3,048,780
3.94% 5
2019
Q4
$26.6M Hold
3,048,780
11.75% 3
2019
Q3
$10.2M Hold
3,048,780
5.75% 4
2019
Q2
$15.1M Hold
3,048,780
6.42% 3
2019
Q1
$18.9M Hold
3,048,780
9.26% 3
2018
Q4
$10.3M Hold
3,048,780
8.61% 3
2018
Q3
$19.8M Hold
3,048,780
8.85% 3
2018
Q2
$23.4M Hold
3,048,780
7.78% 3
2018
Q1
$68.1M Hold
3,048,780
24.53% 2
2017
Q4
$38.9M Buy
+3,048,780
New +$38.9M 13.61% 3